Fosun Pharma Forms China JV with Canada’s Atrium Innovation
Fosun Pharma has formed a China distribution JV with Atrium Innovations, a dietary supplement company headquartered in Canada. Initially, the JV, which will be called Fosium Innovations, will import and sell Atrium’s Pure Encapsulations® line of supplements in China. Atrium paid $1 million for a 49% share of the new JV; Fosun is contributing its distribution network and expertise. Over time, the two companies envision bringing additional Atrium products to China. More details.... Stock Symbols: (SHA: 600196; HK: 2196) (TSX: ATB) Share this with colleagues: // //  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here